DK144942C - Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller deres salte - Google Patents
Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller deres salteInfo
- Publication number
- DK144942C DK144942C DK115976A DK115976A DK144942C DK 144942 C DK144942 C DK 144942C DK 115976 A DK115976 A DK 115976A DK 115976 A DK115976 A DK 115976A DK 144942 C DK144942 C DK 144942C
- Authority
- DK
- Denmark
- Prior art keywords
- alkanophenon
- aminoethyl
- analogue
- salts
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/32—Oximes
- C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
- C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
- C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7503310 | 1975-03-20 | ||
NL7503310A NL7503310A (nl) | 1975-03-20 | 1975-03-20 | Verbindingen met antidepressieve werking. |
Publications (3)
Publication Number | Publication Date |
---|---|
DK115976A DK115976A (da) | 1976-09-21 |
DK144942B DK144942B (da) | 1982-07-12 |
DK144942C true DK144942C (da) | 1982-12-06 |
Family
ID=19823424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK115976A DK144942C (da) | 1975-03-20 | 1976-03-17 | Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller deres salte |
Country Status (27)
Country | Link |
---|---|
US (1) | US4085225A (fi) |
JP (1) | JPS6026776B2 (fi) |
AR (2) | AR211011A1 (fi) |
AT (1) | AT340895B (fi) |
AU (1) | AU505358B2 (fi) |
BE (1) | BE839744A (fi) |
CA (1) | CA1076142A (fi) |
CH (4) | CH626057A5 (fi) |
DD (1) | DD128332A5 (fi) |
DE (1) | DE2610886A1 (fi) |
DK (1) | DK144942C (fi) |
ES (1) | ES446192A1 (fi) |
FI (1) | FI61875C (fi) |
FR (1) | FR2304336A1 (fi) |
GB (1) | GB1535226A (fi) |
GR (1) | GR60052B (fi) |
HU (1) | HU171030B (fi) |
IE (1) | IE43768B1 (fi) |
IL (1) | IL49238A (fi) |
IT (1) | IT1063064B (fi) |
MX (1) | MX9203723A (fi) |
NL (1) | NL7503310A (fi) |
PL (3) | PL101951B1 (fi) |
SE (1) | SE410312B (fi) |
SU (3) | SU635867A3 (fi) |
YU (1) | YU39345B (fi) |
ZA (1) | ZA761434B (fi) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1110460B (it) * | 1977-03-02 | 1985-12-23 | Ciba Geigy Ag | Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego |
FR2639942B1 (fr) * | 1988-12-02 | 1991-03-29 | Sanofi Sa | Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant |
US5665756A (en) * | 1994-08-03 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders |
US6548084B2 (en) * | 1995-07-20 | 2003-04-15 | Smithkline Beecham Plc | Controlled release compositions |
DK0759299T3 (da) * | 1995-08-16 | 2000-08-07 | Lilly Co Eli | Potensering af serotoninrespons |
IN182588B (fi) | 1998-05-12 | 1999-05-08 | Sun Pharmaceutical Ind Ltd | |
IE990406A1 (en) | 1999-05-20 | 2000-12-27 | Elan Corp Plc | Multiparticulate controlled release selective serotonin reuptake inhibitor formulations. |
IN186677B (fi) | 1999-11-12 | 2001-10-20 | Sun Pharmaceutical Ind Ltd | |
US20080021085A1 (en) * | 2000-04-13 | 2008-01-24 | Mayo Foundation For Medical Education And Research | Method of reducing abeta42 and treating diseases |
CA2406383A1 (en) * | 2000-04-13 | 2001-10-25 | Mayo Foundation For Medical Education And Research | A.beta.42 lowering agents |
US7256191B2 (en) * | 2000-04-24 | 2007-08-14 | Aryx Therapeutics | Materials and methods for the treatment of depression |
JP2003531169A (ja) | 2000-04-24 | 2003-10-21 | アリックス セラピューティクス | うつ病治療のための材料と方法 |
CN1606554B (zh) * | 2001-10-12 | 2013-03-20 | 阿泽范药品公司 | β-内酰胺后叶加压素V1a拮抗剂 |
CN1649614A (zh) | 2002-02-22 | 2005-08-03 | 新河药品股份有限公司 | 活性剂传递系统和保护及施用活性剂的方法 |
WO2004071431A2 (en) * | 2003-02-05 | 2004-08-26 | Myriad Genetics, Inc. | Method and composition for treating neurodegenerative disorders |
AU2004311577A1 (en) * | 2003-07-11 | 2005-07-21 | Myriad Genetics, Inc. | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease |
NZ545494A (en) | 2003-09-12 | 2009-10-30 | Pfizer | Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors |
EP1689721B1 (en) * | 2003-11-26 | 2010-07-14 | Pfizer Products Inc. | Aminopyrazole derivatives as gsk-3 inhibitors |
AU2004305563C1 (en) | 2003-12-11 | 2011-07-07 | Sunovion Pharmaceuticals Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
US20070293538A1 (en) * | 2004-04-13 | 2007-12-20 | Myriad Genetics, Incorporated | Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders |
US20050233010A1 (en) * | 2004-04-19 | 2005-10-20 | Satow Philip M | Lithium combinations, and uses related thereto |
MXPA06012165A (es) * | 2004-04-29 | 2007-01-17 | Keystone Retaining Wall System | Chapas para muros, muros de contencion y similares. |
WO2006020850A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
BRPI0514303A (pt) * | 2004-08-11 | 2008-06-10 | Myriad Genetics Inc | composição farmacêutica e método para tratar distúrbios neurodegenerativos |
WO2006020852A2 (en) * | 2004-08-11 | 2006-02-23 | Myriad Genetics, Inc. | Pharmaceutical composition and method for treating neurodegenerative disorders |
EP1868434A4 (en) | 2005-03-22 | 2011-10-26 | Azevan Pharmaceuticals Inc | BETA-LACTAMYL ALKANIC ACIDS FOR THE TREATMENT OF PREMIERSTRUELLEN FAULTS |
TW200718692A (en) | 2005-04-22 | 2007-05-16 | Wyeth Corp | Dihydrobenzofuran derivatives and uses thereof |
BRPI0610785A2 (pt) * | 2005-04-22 | 2016-09-13 | Wyeth Corp | polimorfo cristalino, processo para preparar o mesmo, forma cristalina, composição, e, métodos para tratar uma doença, distúrbios, e uma condição |
AU2006239942A1 (en) * | 2005-04-22 | 2006-11-02 | Wyeth | Dihydrobenzofuran derivatives and uses thereof |
MX2007013021A (es) * | 2005-04-22 | 2008-01-11 | Wyeth Corp | Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c. |
US20070015138A1 (en) * | 2005-07-08 | 2007-01-18 | Braincells, Inc. | Methods for identifying agents and conditions that modulate neurogenesis |
US20070015832A1 (en) * | 2005-07-14 | 2007-01-18 | Myriad Genetics, Incorporated | Methods of treating overactive bladder and urinary incontinence |
EP1910346B1 (en) | 2005-07-19 | 2019-02-27 | Azevan Pharmaceuticals, Inc. | Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonist |
KR20080039876A (ko) * | 2005-07-22 | 2008-05-07 | 미리어드 제네틱스, 인크. | 높은 약물 충진 제형 및 투여형 |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
EP2314289A1 (en) | 2005-10-31 | 2011-04-27 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
FR2912057B1 (fr) * | 2007-02-07 | 2009-04-17 | Sanofi Aventis Sa | Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
TW200806300A (en) * | 2006-03-24 | 2008-02-01 | Wyeth Corp | New therapeutic combinations for the treatment of depression |
JP4615470B2 (ja) * | 2006-03-29 | 2011-01-19 | 卓郎 簑和田 | 大脳の認知力を用いた疾患治療・予防の方法および医薬 |
US7858611B2 (en) * | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | アンジオテンシン調節による神経新生 |
CA2651862A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
EP2046119A2 (en) * | 2006-07-07 | 2009-04-15 | Myriad Genetics, Inc. | Treatment of psychiatric disorders |
TW200817003A (en) * | 2006-07-31 | 2008-04-16 | Sanofi Aventis | Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor |
US7998971B2 (en) | 2006-09-08 | 2011-08-16 | Braincells Inc. | Combinations containing a 4-acylaminopyridine derivative |
US20100016274A1 (en) * | 2006-09-14 | 2010-01-21 | Koppel Gary A | Beta-lactam cannabinoid receptor modulators |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
US20080167363A1 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc | Modulation of Neurogenesis By Melatoninergic Agents |
WO2008086483A2 (en) * | 2007-01-11 | 2008-07-17 | Braincells, Inc. | Modulation of neurogenesis with use of modafinil |
US20110034565A1 (en) | 2008-04-18 | 2011-02-10 | University College Dublin, National University Of Ireland, Dublin | Psycho-pharmaceuticals |
US20100092479A1 (en) * | 2008-08-18 | 2010-04-15 | Combinatorx (Singapore) Pte. Ltd. | Compositions and methods for treatment of viral diseases |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
MX2012004753A (es) | 2009-10-23 | 2012-09-07 | Janssen Pharmaceutica Nv | Octahidropirrolo[3,4-c]pirrolos disustituidos como moduladores del receptor de orexina. |
ES2758554T3 (es) | 2009-12-08 | 2020-05-05 | Univ Case Western Reserve | Aminoácidos gama para tratamiento de trastornos oculares |
EP2587919B1 (en) | 2010-07-01 | 2017-12-13 | Azevan Pharmaceuticals, Inc. | Methods for treating post traumatic stress disorder |
BR112013023810A2 (pt) | 2011-03-17 | 2016-12-13 | Lupin Ltd | composições farmacêuticas de liberação controlada de inibidores seletivos da recaptação de serotonina |
KR101427221B1 (ko) * | 2012-08-29 | 2014-08-13 | 주식회사 에스텍파마 | 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법 |
US9783492B2 (en) | 2013-04-03 | 2017-10-10 | Zcl Chemicals Limited | Process for the preparation of fluvoxamine maleate |
ES2848710T3 (es) | 2014-02-07 | 2021-08-11 | Tamogatott Kutatocsoportok Irodaja | Nuevo uso de compuestos agonistas del receptor sigma-1 |
CN116327950A (zh) | 2014-03-28 | 2023-06-27 | 阿泽范药品公司 | 组合物用于治疗神经退行性疾病的神经精神症状的用途 |
WO2017156266A1 (en) * | 2016-03-10 | 2017-09-14 | Janssen Pharmaceutica Nv | Methods of treating depression using orexin-2 receptor antagonists |
CN110337244B (zh) | 2016-11-24 | 2023-07-21 | 西格玛研究有限责任公司 | 用于器官保藏的组合物 |
TW201919625A (zh) | 2017-09-15 | 2019-06-01 | 美商愛治凡製藥公司 | 用於治療腦損傷之組合物及方法 |
MX2022000709A (es) | 2019-07-19 | 2022-05-19 | Bioxcel Therapeutics Inc | Regimenes de tratamiento con dexmedetomidina no sedante. |
US11806334B1 (en) | 2023-01-12 | 2023-11-07 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3692835A (en) * | 1967-04-05 | 1972-09-19 | Jan Van Dijk | Pharmacologically active amino-ethyl oximes |
-
1975
- 1975-03-20 NL NL7503310A patent/NL7503310A/xx not_active Application Discontinuation
-
1976
- 1976-03-09 ZA ZA761434A patent/ZA761434B/xx unknown
- 1976-03-16 DE DE19762610886 patent/DE2610886A1/de active Granted
- 1976-03-17 PL PL1976199557A patent/PL101951B1/pl unknown
- 1976-03-17 IL IL49238A patent/IL49238A/xx unknown
- 1976-03-17 SE SE7603341A patent/SE410312B/xx not_active IP Right Cessation
- 1976-03-17 GB GB10703/76A patent/GB1535226A/en not_active Expired
- 1976-03-17 IT IT21320/76A patent/IT1063064B/it active Protection Beyond IP Right Term
- 1976-03-17 DK DK115976A patent/DK144942C/da not_active IP Right Cessation
- 1976-03-17 PL PL1976188006A patent/PL100614B1/pl unknown
- 1976-03-17 AT AT195476A patent/AT340895B/de active Protection Beyond IP Right Term
- 1976-03-17 PL PL1976199556A patent/PL100052B1/pl unknown
- 1976-03-17 DD DD7600191893A patent/DD128332A5/xx unknown
- 1976-03-17 SU SU762335241A patent/SU635867A3/ru active
- 1976-03-17 GR GR50333A patent/GR60052B/el unknown
- 1976-03-17 HU HU76PI00000513A patent/HU171030B/hu unknown
- 1976-03-17 FI FI760699A patent/FI61875C/fi not_active IP Right Cessation
- 1976-03-17 CA CA248,102A patent/CA1076142A/en not_active Expired
- 1976-03-17 CH CH334576A patent/CH626057A5/de active Protection Beyond IP Right Term
- 1976-03-18 BE BE165316A patent/BE839744A/xx not_active IP Right Cessation
- 1976-03-18 IE IE567/76A patent/IE43768B1/en not_active IP Right Cessation
- 1976-03-18 YU YU714/76A patent/YU39345B/xx unknown
- 1976-03-18 ES ES446192A patent/ES446192A1/es not_active Expired
- 1976-03-18 AU AU12147/76A patent/AU505358B2/en not_active Expired
- 1976-03-19 JP JP51029394A patent/JPS6026776B2/ja not_active Expired
- 1976-03-19 FR FR7608019A patent/FR2304336A1/fr active Granted
- 1976-03-19 US US05/668,461 patent/US4085225A/en not_active Expired - Lifetime
- 1976-03-22 AR AR262650A patent/AR211011A1/es active
- 1976-12-10 AR AR265801A patent/AR211153A1/es active
-
1977
- 1977-07-12 SU SU772503814A patent/SU645559A3/ru active
- 1977-07-12 SU SU772503815A patent/SU620206A3/ru active
-
1981
- 1981-03-06 CH CH153981A patent/CH629184A5/de not_active IP Right Cessation
- 1981-03-06 CH CH154181A patent/CH629761A5/de not_active IP Right Cessation
- 1981-03-06 CH CH154081A patent/CH629477A5/de not_active IP Right Cessation
-
1992
- 1992-06-29 MX MX9203723A patent/MX9203723A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK144942C (da) | Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller deres salte | |
DK145119C (da) | Analogifremgangsmaade til fremstilling af phenolethere eller syreadditionssalte deraf | |
DK145339C (da) | Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf | |
DK156434C (da) | Analogifremgangsmaade til fremstilling af sulfonylurinstoffer eller deres fysiologisk acceptable salte | |
DK146595C (da) | Analogifremgangsmaade til fremstilling af substituerede 9-alkoxymethyl- eller -alkylthiomethylpuriner eller salte heraf | |
DK152495C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk tolerable salte deraf | |
DK154289C (da) | Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller salte deraf | |
DK149609C (da) | Analogifremgangsmaade til fremstilling af hydroxyamino-alkan- eller -alkenphosphonsyrederivater eller estere eller salte deraf | |
DK5976A (da) | Fremgangsmade til fremstilling af biphenyloxyderivater eller salte heraf | |
DK144525C (da) | Analogifremgangsmaade til fremstilling af 5-halogenpyrimid-2-oner eller salte deraf | |
DK157027C (da) | Fremgangsmaade til fremstilling af 7beta-amino-3-cephem-3-o1-4-carboxylsyreforbindelser eller salte deraf | |
DK209176A (da) | Fremgangsmade til fremstilling af n-substituerede phenylpiperidinderivater eller salte deraf | |
DK145263C (da) | Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf | |
DK159154C (da) | Fremgangsmaade til fremstilling af cephalosporinderivater eller salte deraf | |
DK143278C (da) | Analogifremgangsmaade til fremstilling af n-(r-tetrahydrofurfuryl)-noroxymorphon eller syreadditionssalte deraf | |
DK338376A (da) | Fremgangsmade til fremstilling af aminobenzocycloheptenderivater eller additionssalte deraf | |
DK144301C (da) | Analogifremgangsmaade til fremstilling af penicilliner eller salte deraf | |
DK127676A (da) | Fremgangsmade til fremstilling af 9-alkylamino-erythromyciner eller salte deraf | |
DK156066C (da) | Analogifremgangsmaade til fremstilling af oxaloamino- eller hydroxyacetylaminobenzopyranderivater eller salte deraf med baser | |
DK223177A (da) | Fremgangsmade til fremstilling af p-acylaminobenzamid-forbindelser eller salte deraf | |
DK143844C (da) | Analogifremgangsmaade til fremstilling af alkanophenon-o-(2-aminoethyl)-oximetherforbindelser eller salte deraf | |
DK374576A (da) | Fremgangsmade til fremstilling af 7beta-(d-2-amino-2-(lavalkylsulfonylamino-phenyl)-acetylamino)-3-r-cephem-4-carboxylsyrer eller salte deraf | |
DK147198C (da) | Analogifremgangsmaade til fremstilling af 9-hydroxyethoxymethylguanin-monophosphat eller salte deraf | |
DK408176A (da) | Fremgangsmade til fremstilling af 5-thiazolmethanaminderivater eller salte deraf | |
DK144034C (da) | Analogifremgangsmaade til fremstilling af alkanophenon-0-(2-aminoethyl)-oximforbindelser eller salte deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUP | Patent expired |